These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 25741595)
1. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496 [TBL] [Abstract][Full Text] [Related]
3. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554 [TBL] [Abstract][Full Text] [Related]
4. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1. Zheng WW; Zhou J; Zhang CH; Liu XS Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2541-50. PubMed ID: 27383303 [TBL] [Abstract][Full Text] [Related]
6. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
7. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and Notch signaling in hepatocellular carcinoma. Zhou SJ; Deng YL; Liang HF; Jaoude JC; Liu FY Cell Death Differ; 2017 Sep; 24(9):1577-1587. PubMed ID: 28574502 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma. Tang S; Hu W; Hu J; Wu S; Li J; Luo Y; Cao M; Zhou H; Jiang X Liver Int; 2015 Feb; 35(2):608-19. PubMed ID: 24423280 [TBL] [Abstract][Full Text] [Related]
10. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes]. Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154 [TBL] [Abstract][Full Text] [Related]
11. miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Wei X; Xiang T; Ren G; Tan C; Liu R; Xu X; Wu Z Cell Signal; 2013 Feb; 25(2):439-46. PubMed ID: 23124077 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121 [TBL] [Abstract][Full Text] [Related]
13. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells. Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma. Shi T; Hua Q; Ma Z; Lv Q Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Gao F; Sun X; Wang L; Tang S; Yan C Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974 [TBL] [Abstract][Full Text] [Related]
16. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma. Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124 [TBL] [Abstract][Full Text] [Related]
17. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma. Zhou P; Yao W; Liu L; Yan Q; Chen X; Wei X; Ding S; Lv Z; Zhu F Cell Oncol (Dordr); 2024 Oct; 47(5):1757-1778. PubMed ID: 38753154 [TBL] [Abstract][Full Text] [Related]
18. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma. Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]